Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.
about
Influence of immunoglobulin isotype on therapeutic antibody functionIdentification of potential biomarkers of sepsis using bioinformatics analysis.Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination.Toll-like receptor 2 ligands regulate monocyte Fcγ receptor expression and function.Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies.Anti-tumour strategies aiming to target tumour-associated macrophages.Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity.FcγR requirements leading to successful immunotherapy.Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties.A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells.Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14+CD16+ Monocytes and γδ T Lymphocytes.Soluble fibrinogen-like protein 2 ameliorates acute rejection of liver transplantation in rat via inducing Kupffer cells M2 polarization.
P2860
Q26772080-428BDB0D-6B97-4BA4-83A1-914FB97A7BE5Q33724228-F2016CBB-5C49-4A95-B73F-DE1319F22A3CQ34698758-B990F1EF-709F-4294-AD48-6B942A3B3DEBQ35116211-BEEC94F7-E5E1-4C0D-A1F7-A073343E1AF3Q35510560-03A3A3F3-8662-43F3-B29B-50A848F280F9Q36594664-E179C210-ED14-4F81-A354-F5CCC41BCBDAQ36796964-F894F473-00B5-4AC0-9178-97BA2DD00182Q37168454-5EBA5225-FA98-4943-A682-CDF439E4674DQ38056746-BE1A2D41-0D27-4B2B-A946-D817006D3F22Q38193822-C809B7E7-7949-4C8F-8F0E-2DBB166470ABQ38301125-23782792-7BE0-4727-8101-EE221A4B5BF1Q38615360-FE3A8E86-5FAB-4C4E-A646-A1AE7E442AA4Q38615394-EAC0D695-D142-43E3-9C24-B81BB4BEAEA6Q38736778-4C0DE1B3-22DD-4480-9062-53BBE519BF30Q39192585-C4408917-99A1-4FE9-A107-9EFB64A81275Q41000160-20E50FA9-1909-4821-BE5C-33BED9E949B0Q41072362-47D662C8-6903-4CA4-8C50-4C2D44D0B8C5Q42133572-AA7DD3C7-5F66-456B-BDE5-E1FBF7B63CECQ46050934-B76D9A7B-2F78-4E93-BF13-501D33F886EEQ47556910-7C4EB512-5508-4135-82D0-2C54C5BBF501Q54214817-7968504C-8BA0-4DF9-A70F-8F4707E90B7B
P2860
Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reciprocal regulation of activ ...... tions for tumor immunotherapy.
@ast
Reciprocal regulation of activ ...... tions for tumor immunotherapy.
@en
type
label
Reciprocal regulation of activ ...... tions for tumor immunotherapy.
@ast
Reciprocal regulation of activ ...... tions for tumor immunotherapy.
@en
prefLabel
Reciprocal regulation of activ ...... tions for tumor immunotherapy.
@ast
Reciprocal regulation of activ ...... tions for tumor immunotherapy.
@en
P2093
P2860
P50
P1476
Reciprocal regulation of activ ...... tions for tumor immunotherapy.
@en
P2093
Clay B Marsh
David Jarjoura
Jonathan P Butchar
Kristan D Guenterberg
Natarajan Muthusamy
Payal Mehta
Sri-Vidya Kondadasula
Steven E Justiniano
Susheela Tridandapani
P2860
P304
P356
10.1158/1078-0432.CCR-09-2591
P407
P577
2010-03-23T00:00:00Z